BSEInsider Trading / SAST30 Sept 2026 · 30 Sept 2026, 08:13 pm

CLOSURE OF TRADING WINDOW

Beryl Drugs Ltd · 524606

✦ AI SummaryMgmt Change

Beryl Drugs Ltd has announced the closure of its trading window for all board members, promoters, and connected persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Beryl Drugs Ltd - 524606 - Closure of Trading Window

Attachments (1)

📄

878f1bf5-3b7b-495d-895b-7e4cc02e1593.pdf

pdf

Download →
View document text
BEFEHL DRUGS LIMITED Regd. Off.: 29, Neer Nagar, "Mayank Water Park Road", Bicholi Hapsi, INDORE-452016 (M.P.) INDIA Tel. e: (0731) 2517677 | E-mai Al : beryldrugs25@y ahoo. ecom | CIN : L024 23MP1993PLC007840 Date: 30*" September, 2026 The Secretary, The Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai — 400 001 Sub.: NOTICE FOR CLOSURE TRADING WINDOW IN THE SHARES OF THE COMPANY FOR THE QUARTER ENDED 30" SEPTEMBER, 2026 Scrip Code: 524606 ISIN- INE415H01017 Dear Sir/ Madam, With reference to the BSE circular no LIST/COMP/01/2019-20 dated 2" April, 2019 and in terms of the Code of Conduct adopted by the Company to regulate, monitor and report trading by insiders read with to SEBI (Prohibition of Insider Trading) Regulations, 2015, we hereby submit that the, trading window for dealing in Securities of the Company would remain closed for all the Board Members, Promoters, Designated/ Specified connected persons of the Company from 1 October, 2026 till 48 hours after declaration of the Unaudited Financial Results of the Company for the Quarter ended 30 September, 2026, the date of the Board Meeting for declaration of Unaudited Financial Results of the Company for the Quarter ended on 30" September, 2026 will be intimated in due course. This is for your information and record. For Beryl DrugLsi nid\ /\/J G Sudhir Seth‘ f et Chairman& \\ DIN: 0009017 B